TRIM22 and esophageal squamous cell carcinoma: Western blotting was performed on ESCC cells, and the results demonstrated that the Lyc.HCL treatment significantly suppressed TRIM22 expression in both YES2 and KYSE150 cell lines in a dose-dependent manner (Figure 5E).